NaturalShrimp, Inc., Natural Aquatic Systems (NAS) and

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
455
NaturalShrimp, Inc., Natural Aquatic Systems (NAS) and Hydrenesis, Inc. Presently Testing Their Hydrogas Technology at the Institute of Marine Research in Bergen, Norway < >


11:44 am ET September 9, 2019



via NEWMEDIAWIRE -- NaturalShrimp, Inc. (OTCQB: SHMP), the aquaculture Company that developed and patented the first commercially-operational RAS (Recirculating Aquaculture System) for shrimp, and its majority-owned, technology subsidiary, Natural Aquatic Systems, announced with Hydrenesis, Inc. today that they have delivered one of their water treatment systems to Bergen, Norway to test the system's efficacy in reducing or eliminating the bacteria, viruses and diseases that have decimated both indoor and outdoor aquaculture to date.

The international aquaculture industry is growing annually. The finfish industry is one of the most developed sectors in the industry and its fish farmers are known for being early adopters of new technologies that stimulate sector growth (such as smart-farming platforms, automated centralized feed systems, and new "clean" treatments for wastewater and culture water). The salmon industry, for example, is predominantly using sea cage culture, married with recirculation systems, for smolt and post-smolt production.

Now, larger companies are growing fish to 500g+ before well-boat transfer to sea. The salmon and barramundi industries have been the major targets for Hydrenesis and Natural Aquatic Systems for this proof of concept work. This new testing environment, at one of the top aquaculture research institutes in the world, with over 1,000 employees, will allow us a testing platform to achieve a treatment solution for warmwater finfish and crustaceans, yellowtail kingfish, barramundi, and prawns.

Gerald Easterling, CEO of NaturalShrimp, commented, "We continue to expand our aquaculture capabilities after our initial focus of bringing shrimp to market, and with this development, we are poised to expand our capabilities to additional species as well."

Peter Letizia, CEO of F&T Water Solutions, added: "The Bergen project gives us a great opportunity to test and optimize our industry-leading Hydrogas(R) technology for control and removal of known pathogens in aquaculture wastewater."

David Antelo, CEO of Hydrenesis, said: "We're happy to provide technology that gives NaturalShrimp control over the oxidation processes that create so much havoc in the tanks. We believe that the key to profitability and success in the aquaculture business moving forward will be in eliminating the devastating effects of oxidation using anti-oxidant (reducing) technologies like ours."

ABOUT NATURAL SHRIMP: NaturalShrimp, Inc. is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas. The Company has developed the first commercially viable system for growing shrimp in enclosed, salt-water systems, using patented technology to produce fresh, never frozen, naturally grown shrimp, without the use of antibiotics or toxic chemicals. NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp.

ABOUT F&T WATER SOLUTIONS, LLC: Specializes in Electrocoagulation and Gas and Plasma Infusion Technologies for Desalination and Solids Waste Management for Aquaculture, Food & Beverage Processing, Hydraulic Fracturing, Produced Oil & Natural Gas Wastewater and Landfill Leachate.

ABOUT HYDRENESIS, INC.: Hydrenesis, Inc. is a commercialization company that partners with IP Holders of disruptive technologies to develop and commercialize new markets strategically, without directly challenging industry incumbents or regulators. The Company's technologies deliver unique solutions related to water-related oxidation control, chemical reduction, contaminant removal, neutralization of Nitrogen compounds, desalination, and purification.

Contact: Paul Knopick

pknopick@eandecommunications.com

940.262.3584

NaturalShrimp Inc. (SHMP) Stock Research Links

SHMP Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rate and Betterment's Mortgage Play: Savings or Spin?

Updated Category News Views 151

So here’s the scoop: Rate just teamed up with Betterment on February 17, 2026, offering some pretty slick mortgage incentives for those sitting on at least $100K in their investment accounts. But let’s dig into the nitty-gritty before you start dreaming of that low-rate home loan. Betterment's Strategy: Solid Gains or Hype? The partnership aims to deliver discounted...

Continue Reading
UK Water Companies Gain Confidence After Regulatory Update

Updated Category News Views 253

Morgan Stanley Highlights UK Water Sector Improvements Investment risks surrounding listed UK water companies have significantly decreased following a key regulatory decision concerning water bill increases in England and Wales. According to analysts from Morgan Stanley, this development has created a more favorable landscape for investors in the sector. Key Insights From...

Continue Reading
SiLC Technologies Unveils Advanced Eyeonic Trace Scanner

Updated Category News Views 228

SiLC Technologies Introduces Eyeonic Trace Laser Line Scanner SiLC Technologies, a leader in the development of advanced integrated FMCW LiDAR solutions, recently announced an exciting new product: the Eyeonic Trace Laser Line Scanner. This state-of-the-art Class 1 Laser Line Scanner is engineered to achieve precise measurements of objects from distances of up to 10...

Continue Reading
Accord BioPharma Launches HERCESSI™ for Cancer Treatment

Updated Category News Views 94

Accord BioPharma Announces FDA Approval for HERCESSI™ Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has achieved a major milestone in cancer treatment with the FDA's approval of a new 420mg strength of HERCESSI™ (trastuzumab-strf). This biosimilar to Herceptin (trastuzumab) targets different types of HER2-overexpressing cancers, such as...

Continue Reading
Why Oklo Stock is Soaring This Week and What to Expect

Updated Category News Views 493

What’s Driving Oklo Inc’s Stock Surge? Oklo Inc (NYSE: OKLO) is making waves in the stock market as its shares witness impressive growth. Over the past month, the company has experienced a remarkable rally of approximately 60%. Investors are keen to learn about the driving forces behind this upward trend. Recent Positive Developments This recent surge can primarily be...

Continue Reading